Becton Dickinson boosts quarterly dividend

Becton Dickinson's ($BDX) board of directors boosted its quarterly dividend to 54.5 cents per common share, up 10% from the previous quarter. Lucky shareholders-of-record as of Dec. 10 get to reap the benefit on Dec. 31. That means the New Jersey maker of medical instruments and reagents will be hitting a $2.18 per share annual dividend for fiscal 2014. Becton Dickinson Chairman, CEO and President Vincent Forlenza noted in a statement that this is the 42nd consecutive year that the company raised its dividend. Becton Dickinson closed out its 2013 fiscal year with $2.1 billion in revenue during the fourth quarter, nearly 7% higher than the $2 billion booked during the same period last year. But the company's net income plunged due to its defeat in an antitrust civil trial. Item

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Hand-held ultrasound developer Butterfly Network is going public through a $1.5 billion acquisition deal backed by Glenview Capital.